cannabis indica

Dor — Polineuropatia Inflamatória

termo de indexação original: Pain - Neuropathy - Inflammatory Polyneuropathy

O acervo do Cannabis Indica reúne 61 estudos científicos que tocam a condição Dor — Polineuropatia Inflamatória, publicados entre 2004 e 2024. Pela leitura automatizada, 49 (80%) foram classificados como favoráveis, 5 (8%) como inconclusivos e 7 (11%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é estudo em animais (22 estudos), seguido de metanálise (17). Os compostos mais presentes são Anandamida (AEA), Tetraidrocanabinol (THC) e Palmitoiletanolamida (PEA). Aparece com frequência ao lado de Dor, Dor — Neuropatia Periférica e Inflamação.

Estudos indexados
61
Período coberto
2004–2024
Favoráveis
49 · 80%
Inconclusivos
5 · 8%
Desfavoráveis
7 · 11%
Termo original
Pain - Neuropathy - Inflammatory Polyneuropathy

O acervo em números

Tipo de estudo

Estudo em Animais22
Metanálise17
Metanálise Clínica11
Estudo Laboratorial6
Ensaio Clínico Duplo-Cego3
Ensaio Clínico2

Direção do resultado

Favorável49
Inconclusivo5
Desfavorável7

Por década

2000s9
2010s27
2020s25

61 estudos

Filtrar e buscar no acervo →
  1. 2024

    Design of Mixed Medicinal Plants, Rich in Polyphenols, Vitamins B, and Palmitoylethanolamide-Based Supplement to Help Reduce Nerve Pain: A Preclinical Study

    FavorávelEstudo LaboratorialDorInflamaçãoEstresse OxidativoPalmitoiletanolamida (PEA)+3
  2. 2024

    The role of cannabinoids in chronic pain management: clinical insights and challenges

    InconclusivoMetanáliseDorInflamaçãoDor — Crônica+4
  3. 2024

    Transdermal Delivery of Cannabidiol for the Management of Acute Inflammatory Pain: A Comprehensive Review of the Literature

    FavorávelMetanáliseDorDor — Dentária AgudaCBD Farmacêutico
  4. 2023

    Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms

    DesfavorávelMetanálise ClínicaDor — CrônicaDor — AgudaDor — Neuropatia Periférica+6
  5. 2023

    Structure-Based Virtual Screening and Molecular Dynamics Simulation Assessments of Depsidones as Possible Selective Cannabinoid Receptor Type 2 Agonists

    FavorávelEstudo LaboratorialDorInflamaçãoInfecções BacterianasEndocanabinoide (não especificado)+3
  6. 2022

    Advanced Meditation and Vegan Diet Increased Acylglycines and Reduced Lipids Associated with Improved Health: A Prospective Longitudinal Study

  7. 2022

    Cannabidiol attenuates hypersensitivity and oxidative stress after traumatic spinal cord injury in rats

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Crônica+3
  8. 2022

    Cannabinoids for Symptom Management in Patients with Kidney Failure: A Narrative Review

    DesfavorávelMetanáliseDorInflamaçãoAnsiedade+10
  9. 2022

    Comparative Efficacy and Safety of 11 Drugs as Therapies for Adults With Neuropathic Pain After Spinal Cord Injury: A Bayesian Network Analysis Based on 20 Randomized Controlled Trials

    InconclusivoMetanálise ClínicaDorInsônia e Distúrbios do SonoDor — Neuropatia Periférica+1
  10. 2022

    Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders

  11. 2022

    Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment

    DesfavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaPsicose+3
  12. 2022

    Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence

    FavorávelMetanálise ClínicaDorInflamaçãoDisfunção CognitivaPalmitoiletanolamida (PEA)+8
  13. 2022

    TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids

  14. 2021

    Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians

    FavorávelMetanáliseDorInflamaçãoDor — Crônica+1
  15. 2021

    Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials

    InconclusivoMetanálise ClínicaDorDor — CrônicaDor — AgudaTHC FarmacêuticoTHC:CBD Farmacêutico+5
  16. 2021

    Cost-Effectiveness of Medicinal Cannabis for Management of Refractory Symptoms Associated With Chronic Conditions: A Systematic Review of Economic Evaluations

  17. 2021

    Efficacy of a fixed combination of palmitoylethanolamide and acetyl-l-carnitine (PEA+ALC FC) in the treatment of neuropathies secondary to rheumatic diseases

    FavorávelEnsaio ClínicoDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)+3
  18. 2021

    International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management

    FavorávelMetanáliseDorDor — CrônicaDor — Aguda+5
  19. 2021

    Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain

  20. 2021

    The terpenes camphene and alpha-bisabolol inhibit inflammatory and neuropathic pain via Cav3.2 T-type calcium channels

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Crônica+1
  21. 2020

    Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination

  22. 2020

    Pharmacological treatment of central neuropathic pain: consensus of the Brazilian Academy of Neurology

  23. 2020

    The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis

    FavorávelMetanálise ClínicaDorEsclerose MúltiplaDor — Neuropatia Periférica
  24. 2020

    The Cannabis Terpenes

    FavorávelMetanáliseDorCâncerInflamação+10
  25. 2020

    Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat

    FavorávelEstudo em AnimaisDorInflamaçãoEstresse OxidativoPalmitoiletanolamida (PEA)+2
  26. 2019

    Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity

  27. 2018

    Effect of cannabidiolic acid and ∆ 9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain

    FavorávelEstudo em AnimaisDorTetraidrocanabinol (THC)Canabinoides Sintéticos AM-x+2
  28. 2018

    The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation.

  29. 2018

    The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain

    FavorávelMetanáliseDorAnandamida (AEA)Tetraidrocanabinol (THC)+7
  30. 2018

    The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine

    FavorávelEstudo em AnimaisDorDor — Neuropatia Periférica
  31. 2017

    Cannabinoids and Pain: Sites and Mechanisms of Action.

  32. 2017

    Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain.

  33. 2017

    Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnsiedadeTHC Farmacêutico+4
  34. 2017

    Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    FavorávelMetanálise ClínicaDorDor — CrônicaDor — Neuropatia Periférica+2
  35. 2017

    Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.

  36. 2017

    Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis

  37. 2017

    Use of palmitoylethanolamide in carpal tunnel syndrome: a prospective randomized study

    InconclusivoEnsaio Clínico Duplo-CegoDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)+5
  38. 2016

    Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC.

    DesfavorávelEstudo em AnimaisDorDoenças NeurodegenerativasDoenças da Retina+2
  39. 2015

    (+)-Borneol alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Crônica+1
  40. 2015

    Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials

    FavorávelMetanálise ClínicaDorDor — CrônicaEsclerose MúltiplaTetraidrocanabinol (THC)+5
  41. 2015

    Linalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-κB activation.

    FavorávelEstudo em AnimaisDorInflamaçãoDependência — Nicotina
  42. 2015

    Physicochemical characterization and analgesic effect of inclusion complexes of essential oil from Hyptis pectinata L. Poit leaves with β-cyclodextrin.

    FavorávelEstudo em AnimaisDorDor — Neuropatia Periférica
  43. 2014

    In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects

  44. 2014

    Phytol, a diterpene alcohol, inhibits the inflammatory response by reducing cytokine production and oxidative stress.

    FavorávelEstudo em AnimaisDorEstresse Oxidativo
  45. 2013

    Antinociceptive Activity and Redox Profile of the Monoterpenes (+)-Camphene, p-Cymene, and Geranyl Acetate in Experimental Models.

    FavorávelEstudo em AnimaisDor
  46. 2013

    Antinociceptive and Antioxidant Activities of Phytol In Vivo and In Vitro Models.

    FavorávelEstudo em AnimaisDorEstresse Oxidativo
  47. 2013

    Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans.

    FavorávelEstudo em AnimaisDorDII — Doença Inflamatória IntestinalAcne
  48. 2013

    Two novel mutations in ABHD12: expansion of the mutation spectrum in PHARC and assessment of their functional effects.

  49. 2011

    Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress.

  50. 2011

    Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.

    FavorávelEstudo LaboratorialDorAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)+9
  51. 2011

    Limonene, a natural cyclic terpene, is an agonistic ligand for adenosine A(2A) receptors.

    FavorávelEstudo LaboratorialDorAcne
  52. 2010

    Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

    FavorávelMetanálise ClínicaDorDor — Neuropatia PeriféricaHIV/AIDS
  53. 2009

    Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous)

    DesfavorávelMetanálise ClínicaDorDor — Neuropatia Periférica
  54. 2008

    Complementary therapies for neuropathic and neuralgic pain: systematic review

    DesfavorávelMetanálise ClínicaDorDor — Neuropatia PeriféricaDor — Neuropatia Diabética+1
  55. 2008

    Pharmacokinetics and tissue distribution of the sesquiterpene alpha-humulene in mice.

    FavorávelEstudo em AnimaisDor
  56. 2007

    Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.

    FavorávelEstudo em AnimaisDorAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  57. 2005

    Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat

  58. 2005

    Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin.

    FavorávelEstudo em AnimaisDor
  59. 2005

    Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies.

  60. 2005

    Therapeutic opportunities through modulation of the endocannabinoid system

  61. 2004

    Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.

    FavorávelEstudo em AnimaisDorCanabinoides Sintéticos SR-x

Continue por aqui

Perguntas frequentes

Quantos estudos sobre dor — polineuropatia inflamatória estão indexados no acervo?
São 61 estudos, publicados entre 2004 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Estudo em Animais: 22 · Metanálise: 17 · Metanálise Clínica: 11 · Estudo Laboratorial: 6 · Ensaio Clínico Duplo-Cego: 3 · Ensaio Clínico: 2. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 49 favoráveis, 5 inconclusivos e 7 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Dor — Polineuropatia Inflamatória — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/dor-polineuropatia-inflamatoria/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Dor — Polineuropatia Inflamatória — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/dor-polineuropatia-inflamatoria/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.